Addus HomeCare Co. (NASDAQ:ADUS) Receives $131.63 Consensus Target Price from Analysts

Addus HomeCare Co. (NASDAQ:ADUS) has received a consensus rating of “Moderate Buy” from the nine analysts that are currently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have covered the stock in the last year is $131.63.

ADUS has been the topic of a number of research reports. KeyCorp assumed coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They set an “overweight” rating and a $150.00 target price on the stock. StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a research report on Wednesday. Royal Bank of Canada reissued an “outperform” rating and set a $136.00 target price on shares of Addus HomeCare in a research report on Thursday, November 14th. Oppenheimer upped their price target on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, Stephens lifted their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a report on Wednesday, November 6th.

Insider Buying and Selling at Addus HomeCare

In related news, CEO R Dirk Allison sold 12,500 shares of Addus HomeCare stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the completion of the transaction, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction dated Monday, December 9th. The shares were sold at an average price of $121.00, for a total transaction of $272,250.00. Following the completion of the transaction, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

A number of large investors have recently bought and sold shares of ADUS. UMB Bank n.a. boosted its stake in Addus HomeCare by 64.2% in the second quarter. UMB Bank n.a. now owns 225 shares of the company’s stock worth $26,000 after purchasing an additional 88 shares in the last quarter. Quarry LP acquired a new position in Addus HomeCare during the 3rd quarter worth about $28,000. Quest Partners LLC bought a new stake in Addus HomeCare during the 2nd quarter worth about $31,000. Innealta Capital LLC acquired a new stake in Addus HomeCare in the 2nd quarter valued at about $44,000. Finally, Farther Finance Advisors LLC raised its stake in shares of Addus HomeCare by 9,150.0% in the third quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock worth $49,000 after acquiring an additional 366 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.

Addus HomeCare Stock Performance

Shares of NASDAQ:ADUS opened at $125.00 on Friday. The stock’s 50-day moving average is $125.64 and its 200-day moving average is $124.37. The company has a market cap of $2.27 billion, a P/E ratio of 28.60, a P/E/G ratio of 2.11 and a beta of 1.01. Addus HomeCare has a 52-week low of $85.94 and a 52-week high of $136.12.

Addus HomeCare (NASDAQ:ADUS) last released its earnings results on Monday, November 4th. The company reported $1.30 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. During the same quarter last year, the firm posted $1.03 EPS. The company’s revenue was up 7.1% on a year-over-year basis. As a group, equities analysts predict that Addus HomeCare will post 4.59 EPS for the current year.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.